FMOC-PHE-THR(PSI-ME,ME PRO)-OH
|
|
|
- CAS-Nr.
- 1196703-48-6
- Englisch Name:
- FMOC-PHE-THR(PSI-ME,ME PRO)-OH
- Synonyma:
- Fmoc-Phe-Thr(YMe, MePro)-OH;Reaxys ID: 19854654;Fmoc-Phe-Thr[Ψ(Me,Me)Pro]-OH;Fmoc-L-Phe-L-Thr[Me,MePro]-OH;Fmoc-L-Phe-ThrPsi(Me,Me)Pro-OH;FMOC-PHE-THR(PSI-ME,ME PRO)-OH;Fmoc-L-Phe-L-Thr[PSI(Me,Me)Pro;Fmoc-Phe-Thr(Psi(Me00Me)pro)-OH;Fmoc-L-Phe-L-Thr[PSI(Me,Me)Pro]-OH;FMOC-PHE-THR(ΨME,ME PRO)-OH_1196703-48-6
- CBNumber:
- CB6172839
- Summenformel:
- C31H32N2O6
- Molgewicht:
- 528.6
- MOL-Datei:
- 1196703-48-6.mol
|
FMOC-PHE-THR(PSI-ME,ME PRO)-OH Eigenschaften
- Siedepunkt:
- 764.4±60.0 °C(Predicted)
- Dichte
- 1.258±0.06 g/cm3(Predicted)
- storage temp.
- Store at +2°C to +8°C.
- pka
- 3.14±0.60(Predicted)
- Aggregatzustand
- powder
- Major Application
- peptide synthesis
- InChIKey
- FFOYZGOZWLCJDO-VHEIIQRDSA-N
- SMILES
- O1[C@H](C)[C@@H](C(O)=O)N(C(=O)[C@@H](NC(OCC2C3=C(C=CC=C3)C3=C2C=CC=C3)=O)CC2=CC=CC=C2)C1(C)C
FMOC-PHE-THR(PSI-ME,ME PRO)-OH Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
White to off-white powder
Verwenden
Fmoc-Phe-Thr(psime,MePro)-OH is used as a reactant in the synthesis of GUB06-046, a novel secretin/glucagon-like peptide 1 co-agonist.
FMOC-PHE-THR(PSI-ME,ME PRO)-OH Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
FMOC-PHE-THR(PSI-ME,ME PRO)-OH Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 94)Lieferanten
- Fmoc-L-Phe-L-Thr[PSI(Me,Me)Pro]-OH
- FMOC-PHE-THR(PSI-ME,ME PRO)-OH
- (4S,5R)-3-[N-(9-Fluorenylmethyloxycarbonyl)-L-phenylalaninyl]-2,2,5-trimethyloxazolidine-4-carboxylic acid
- Fmoc-Phe-Thr[Psi(Me,Me)Pro]-OH≥ 99% (HPLC)
- Fmoc-Phe-Thr[Ψ(Me,Me)Pro]-OH
- (4S,5R)-3-[(2S)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-1-oxo-3-phenylpropyl]-2,2,5-trimethyl-4-oxazolidinecarboxylic acid
- (4S,5R)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanoyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid
- Fmoc-L-Phe-ThrPsi(Me,Me)Pro-OH
- (4S,5R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)-L-phenylalanyl)-2,2,5-trimethyloxazolidine-4-carboxylicacid
- 4-Oxazolidinecarboxylic acid, 3-[(2S)-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1-oxo-3-phenylpropyl]-2,2,5-trimethyl-, (4S,5R)-
- (9H-Fluoren-9-yl)MethOxy]Carbonyl Phe-ThrPsi(Me,Me)Pro-OH
- FMOC-PHE-THR(ΨME,ME PRO)-OH_1196703-48-6
- (4S,5R)-3-[(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-phenylpropanoyl]-2,2,5-trimethyl-1,3-oxazolidine-4-carboxylic acid
- Fmoc-L-Phe-L-Thr[PSI(Me,Me)Pro
- Reaxys ID: 19854654
- Fmoc-L-Phe-L-Thr[Me,MePro]-OH
- Fmoc-Phe-Thr(Psi(Me00Me)pro)-OH
- (4S,5R)-3-((S)-2-((((9H-fluorene-9-yl)methoxy)carbonyl)amino)-3-phenylpropylacyl)-2,2,5-trimethylazolealkane-4-carboxylic acid
- Fmoc-Phe-Thr(YMe, MePro)-OH
- 22(4S,5R)-3-[(2S)-2-[[fluorenemethoxycarbonyl]amino]-1-oxo-3-phenyl]-2,2,5-trimethyl-4-oxazolidinecarboxylic acid
- 1196703-48-6
- peptide
